Journal List > Tuberc Respir Dis > v.72(1) > 1001704

Kim, Choi, and Hong: The Treatment of Adult Respiratory Distress Syndrome (ARDS) Using Extracorporeal Membrane Oxygenation (ECMO)

Abstract

Extracorporeal Membrane Oxygenation (ECMO) support to tissue oxygenation has been shown to improve survival in patients with life threatening respiratory distress syndrome or cardiac failure. Extracorporeal life support such as ECMO, including extracorporeal CO2 removal (ECCO2R), is used as temporary support until successful recovery of organs. A recently published multicentre randomized controlled trial, known as the CESAR (conventional ventilation or extracorporeal membrane oxygenation for severe adult respiratory failure) trial, was the first trial to demonstrate the utility of ECMO in acute respiratory distress syndrome (ARDS). During the 2009 influenza A (H1N1) pandemic, there were many reports of patients with severe ARDS related to H1N1 infection treated with ECMO. These reports revealed a high survival rate and effectiveness of ECMO. In this review, we explain the indication of ECMO clinical application, the practical types of ECMO, and complications associated with ECMO. In addition, we explain recent new ECMO technology and management of patients during ECMO support.

Figures and Tables

Figure 1
(A) Recirculation phenomenon. (B) Dual-lumen cannula. This figure was reprinted from NEJM 2011:365:1905-14.
trd-72-1-g001
Table 1
ECMO on adult respiratory failure
trd-72-1-i001

ECMO: extracorporeal membrane oxygenation; ANC: absolute neutrophil count.

References

1. de Prost N, Ricard JD, Saumon G, Dreyfuss D. Ventilator-induced lung injury: historical perspectives and clinical implications. Ann Intensive Care. 2011. 1:28.
2. Terragni PP, Rosboch G, Tealdi A, Corno E, Menaldo E, Davini O, et al. Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2007. 175:160–166.
3. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009. 374:1351–1363.
4. Higgins AM, Pettilä V, Harris AH, Bailey M, Lipman J, Seppelt IM, et al. The critical care costs of the influenza A/H1N1 2009 pandemic in Australia and New Zealand. Anaesth Intensive Care. 2011. 39:384–391.
5. Patroniti N, Zangrillo A, Pappalardo F, Peris A, Cianchi G, Braschi A, et al. The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks. Intensive Care Med. 2011. 37:1447–1457.
6. Choi H, Lee WG, Lee SM, Moon HS, Chung YK, Lee KH, et al. Prolonged extracorporeal lung heart assist (extracorporeal membrane oxygenation) - 4 cases report. Korean J Anesthesiol. 1992. 25:424–432.
7. Bartlett RH, Gazzaniga AB, Huxtable RF, Schippers HC, O'Connor MJ, Jefferies MR. Extracorporeal circulation (ECMO) in neonatal respiratory failure. J Thorac Cardiovasc Surg. 1977. 74:826–833.
8. Morioka T. Extracorporeal lung assist: ECLA. Kyobu Geka. 1989. 42:766–767.
9. Gattinoni L, Pesenti A, Pelizzola A, Caspani ML, Iapichino G, Agostoni A, et al. Reversal of terminal acute respiratory failure by low frequency positive pressure ventilation with extracorporeal removal of CO2 (LFPPV-ECCO2R). Trans Am Soc Artif Intern Organs. 1981. 27:289–293.
10. Marasco SF, Lukas G, McDonald M, McMillan J, Ihle B. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. Heart Lung Circ. 2008. 17:Suppl 4. S41–S47.
11. Extracorporeal Life Support Organization [Homepage]. c2011. cited 2011 Nov 25. Ann Arbor, MI: ELSO;Available from: http://www.elso.med.umich.edu/Guidelines.html.
12. Zapol WM, Snider MT, Hill JD, Fallat RJ, Bartlett RH, Edmunds LH, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA. 1979. 242:2193–2196.
13. Hemmila MR, Rowe SA, Boules TN, Miskulin J, McGillicuddy JW, Schuerer DJ, et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg. 2004. 240:595–605.
14. Lin TY, Horng FM, Chiu KM, Chu SH, Shieh JS. A simple modification of inflow cannula to reduce recirculation of venovenous extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 2009. 138:503–506.
15. Liebold A, Reng CM, Philipp A, Pfeifer M, Birnbaum DE. Pumpless extracorporeal lung assist - experience with the first 20 cases. Eur J Cardiothorac Surg. 2000. 17:608–613.
16. Reng M, Philipp A, Kaiser M, Pfeifer M, Gruene S, Schoelmerich J. Pumpless extracorporeal lung assist and adult respiratory distress syndrome. Lancet. 2000. 356:219–220.
17. Bein T, Weber F, Philipp A, Prasser C, Pfeifer M, Schmid FX, et al. A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med. 2006. 34:1372–1377.
18. Zimmermann M, Bein T, Arlt M, Philipp A, Rupprecht L, Mueller T, et al. Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study. Crit Care. 2009. 13:R10.
19. Chen YS, Lin JW, Yu HY, Ko WJ, Jerng JS, Chang WT, et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet. 2008. 372:554–561.
20. Chen YS, Chao A, Yu HY, Ko WJ, Wu IH, Chen RJ, et al. Analysis and results of prolonged resuscitation in cardiac arrest patients rescued by extracorporeal membrane oxygenation. J Am Coll Cardiol. 2003. 41:197–203.
21. Cardarelli MG, Young AJ, Griffith B. Use of extracorporeal membrane oxygenation for adults in cardiac arrest (E-CPR): a meta-analysis of observational studies. ASAIO J. 2009. 55:581–586.
22. Thiagarajan RR, Brogan TV, Scheurer MA, Laussen PC, Rycus PT, Bratton SL. Extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in adults. Ann Thorac Surg. 2009. 87:778–785.
23. Jackson A, Cropper J, Pye R, Junius F, Malouf M, Glanville A. Use of extracorporeal membrane oxygenation as a bridge to primary lung transplant: 3 consecutive, successful cases and a review of the literature. J Heart Lung Transplant. 2008. 27:348–352.
24. Olsson KM, Simon A, Strueber M, Hadem J, Wiesner O, Gottlieb J, et al. Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant. 2010. 10:2173–2178.
25. Mangi AA, Mason DP, Yun JJ, Murthy SC, Pettersson GB. Bridge to lung transplantation using short-term ambulatory extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 2010. 140:713–715.
26. Bermudez CA, Rocha RV, Zaldonis D, Bhama JK, Crespo MM, Shigemura N, et al. Extracorporeal membrane oxygenation as a bridge to lung transplant: midterm outcomes. Ann Thorac Surg. 2011. 92:1226–1231.
27. Mason DP, Thuita L, Nowicki ER, Murthy SC, Pettersson GB, Blackstone EH. Should lung transplantation be performed for patients on mechanical respiratory support? The US experience. J Thorac Cardiovasc Surg. 2010. 139:765–773.
28. Hämmäinen P, Schersten H, Lemström K, Riise GC, Kukkonen S, Swärd K, et al. Usefulness of extracorporeal membrane oxygenation as a bridge to lung transplantation: a descriptive study. J Heart Lung Transplant. 2011. 30:103–107.
29. Agati S, Ciccarello G, Fachile N, Scappatura RM, Grasso D, Salvo D, et al. DIDECMO: a new polymethylpentene oxygenator for pediatric extracorporeal membrane oxygenation. ASAIO J. 2006. 52:509–512.
30. Toomasian JM, Schreiner RJ, Meyer DE, Schmidt ME, Hagan SE, Griffith GW, et al. A polymethylpentene fiber gas exchanger for long-term extracorporeal life support. ASAIO J. 2005. 51:390–397.
31. Rhee I, Kwon SU, Sung K, Cho SW, Gwon HC, Lee YT, et al. Experiences with emergency percutaneous cardiopulmonary support in in-hospital cardiac arrest or cardiogenic shock due to the ischemic heart disease. Korean J Thorac Cardiovasc Surg. 2006. 39:201–207.
32. Plötz FB, van Oeveren W, Bartlett RH, Wildevuur CR. Blood activation during neonatal extracorporeal life support. J Thorac Cardiovasc Surg. 1993. 105:823–832.
33. Robinson TM, Kickler TS, Walker LK, Ness P, Bell W. Effect of extracorporeal membrane oxygenation on platelets in newborns. Crit Care Med. 1993. 21:1029–1034.
34. Thelin S, Bagge L, Hultman J, Borowiec J, Nilsson L, Thorelius J. Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig. Eur J Cardiothorac Surg. 1991. 5:486–491.
35. Videm V, Svennevig JL, Fosse E, Semb G, Osterud A, Mollnes TE. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg. 1992. 103:806–813.
36. Borowiec J, Thelin S, Bagge L, Nilsson L, Venge P, Hansson HE. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study. J Thorac Cardiovasc Surg. 1992. 104:642–647.
37. Glauber M, Szefner J, Senni M, Gamba A, Mamprin F, Fiocchi R, et al. Reduction of haemorrhagic complications during mechanically assisted circulation with the use of a multi-system anticoagulation protocol. Int J Artif Organs. 1995. 18:649–655.
38. van der Staak FH, de Haan AF, Geven WB, Festen C. Surgical repair of congenital diaphragmatic hernia during extracorporeal membrane oxygenation: hemorrhagic complications and the effect of tranexamic acid. J Pediatr Surg. 1997. 32:594–599.
39. Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008. 358:2319–2331.
40. Horwitz JR, Cofer BR, Warner BW, Cheu HW, Lally KP. A multicenter trial of 6-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO. J Pediatr Surg. 1998. 33:1610–1613.
TOOLS
Similar articles